Among patients who have had an ischemic stroke or transient ischemic attack (TIA), type 2 diabetes was associated with an increased risk of recurrent stroke or cardiovascular events, but metabolic syndrome was not, according ...
Jun 13, 2011
0
0
A woman's risk of developing diabetes during pregnancy can be identified up to seven years before she becomes pregnant based on routinely assessed measures of blood sugar and body weight, according to a Kaiser Permanente ...
May 26, 2011
0
0
A physician panel in the primary care specialty of internal medicine has identified common clinical activities where changes in practice could lead to higher quality care and better use of finite clinical resources.
May 23, 2011
0
0
Hair grooming practices, such as braids and weaves, as well as inflammation in the form of bacterial infection, may be contributing to the development of scarring hair loss in African American women, according to a report ...
Apr 11, 2011
0
0
Insulin degludec (trade name: Tresiba) has been approved since January 2015 for adolescents and children from the age of one year with type 1 or type 2 diabetes mellitus. In an early benefit assessment pursuant to the Act ...
Jun 1, 2015
0
6
New research published in Diabetologia (the journal of the European Association for the Study of Diabetes) shows that in women who have developed gestational diabetes mellitus (GDM) during pregnancy, being obese before the ...
Mar 18, 2015
0
14
Melatonin is a natural hormone segregated by the body and melatonin levels generally increase in the dark at night. It is also found in fruit and vegetables like mustard, Goji berries, almonds, sunflower seeds, cardamom, ...
Sep 25, 2013
0
1
The DiMelli (Diabetes Mellitus Incidence Cohort Registry) study examines the frequency and characteristics of diabetes phenotypes in children and young adults below the age of 20. The study was commissioned to investigate ...
Sep 12, 2013
0
0
Patients with type 2 diabetes and high cardiovascular risk due to recent acute coronary syndromes had similar rates of cardiovascular events when treated with the anti-diabetic agent alogliptin compared to placebo according ...
Sep 2, 2013
0
0
Lixisenatide (trade name: Lyxumia) has been approved in Germany since February 2013 for the treatment of type 2 diabetes mellitus in combination with oral blood-glucose lowering drugs or basal insulin when these, together ...
Aug 2, 2013
0
0
